The therapeutic potential of resolvins in pulmonary diseases
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference144 articles.
1. Resolvins: emerging players in autoimmune and inflammatory diseases;Abdolmaleki;Clin. Rev. Allergy Immunol.,2020
2. Resolvin E1's antimicrobial potential against Aggregatibacter actinomycetemcomitans;Abdullatif;Front. Oral Health,2022
3. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients;Archambault;Faseb. J.,2021
4. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1;Arita;J. Exp. Med.,2005
5. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation;Arita;J. Immunol.,2007
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biosynthesis of resolvin D1, resolvin D2, and RCTR1 from 7,8(S,S)-epoxytetraene in human neutrophils and macrophages;Proceedings of the National Academy of Sciences;2024-09-05
2. Cancer treatments as paradoxical catalysts of tumor awakening in the lung;Cancer and Metastasis Reviews;2024-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3